📌 Controversies in #HeartFailure
SGLT2 Inhibitors Should Be Given to All Patients⁉️
What is the best glucose lowering therapy to treat T2D in👥with #HFpEF⁉️
Prof. McMurray
#ESCCongress
@paomorejon @ESC_Lavinia @escardio @ShelleyZieroth @hvanspall @HanCardiomd @MihaiTrofenciuc
SGLT2 Inhibitors Should Be Given to All Patients⁉️
What is the best glucose lowering therapy to treat T2D in👥with #HFpEF⁉️
Prof. McMurray
#ESCCongress
@paomorejon @ESC_Lavinia @escardio @ShelleyZieroth @hvanspall @HanCardiomd @MihaiTrofenciuc
📌 SGLT2 Inhibitors Should Be Given to All Patients⁉️
#DAPA -HF
Not representative of all HF
Subgroups where iSGLT2 don’t work
👥were undertreated
Prof. De Boer
#ESCCongress
@paomorejon @escardio
#DAPA -HF
Not representative of all HF
Subgroups where iSGLT2 don’t work
👥were undertreated
Prof. De Boer
#ESCCongress
@paomorejon @escardio
📌 SGLT2 Inhibitors Should Be Given to All Patients⁉️
We aren’t making changes
#ESCCongress
@paomorejon @escardio
We aren’t making changes
#ESCCongress
@paomorejon @escardio
• • •
Missing some Tweet in this thread? You can try to
force a refresh
